| Entry |
|
|---|
| Name |
Fumarate;
Fumaric acid;
trans-Butenedioic acid
|
|---|
| Formula |
C4H4O4
|
|---|
| Exact mass |
116.011
|
|---|
| Mol weight |
116.0722
|
|---|
| Structure |
   |
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00250 | Alanine, aspartate and glutamate metabolism |
| map00720 | Carbon fixation pathways in prokaryotes |
| map00760 | Nicotinate and nicotinamide metabolism |
| map01060 | Biosynthesis of plant secondary metabolites |
| map01061 | Biosynthesis of phenylpropanoids |
| map01062 | Biosynthesis of terpenoids and steroids |
| map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
| map01064 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid |
| map01065 | Biosynthesis of alkaloids derived from histidine and purine |
| map01066 | Biosynthesis of alkaloids derived from terpenoid and polyketide |
| map01110 | Biosynthesis of secondary metabolites |
| map01120 | Microbial metabolism in diverse environments |
| map01220 | Degradation of aromatic compounds |
| map05230 | Central carbon metabolism in cancer |
|
|---|
| Module |
| M00009 | Citrate cycle (TCA cycle, Krebs cycle) |
| M00011 | Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate |
| M00044 | Tyrosine degradation, tyrosine => homogentisate |
| M00148 | Succinate dehydrogenase (ubiquinone) |
| M00149 | Succinate dehydrogenase, prokaryotes |
| M00150 | Fumarate reductase, prokaryotes |
| M00173 | Reductive citrate cycle (Arnon-Buchanan cycle) |
| M00374 | Dicarboxylate-hydroxybutyrate cycle |
| M00376 | 3-Hydroxypropionate bi-cycle |
| M00620 | Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate |
| M00622 | Nicotinate degradation, nicotinate => fumarate |
| M00844 | Arginine biosynthesis, ornithine => arginine |
| M00845 | Arginine biosynthesis, glutamate => acetylcitrulline => arginine |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05AX Other antipsoriatics for topical use
D05AX01 Fumaric acid
D02308 Fumaric acid (NF)
Pharmaceutical additives in Japan [BR:br08316]
Stabilizing agent
D02308 [102419] Fumaric acid
Lubricating agent
D02308 [102419] Fumaric acid
Flavoring substance
D02308 [102419] Fumaric acid
Bonding agent
D02308 [102419] Fumaric acid
 |
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 8
1 C6a C 20.4406 -15.2590
2 C2b C 21.6516 -15.9610
3 O6a O 19.2297 -15.9610
4 O6a O 20.4406 -13.8609
5 C2b C 22.8684 -15.2590
6 C6a C 24.0794 -15.9610
7 O6a O 25.2903 -15.2590
8 O6a O 24.0794 -17.3591
BOND 7
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 2
5 5 6 1
6 6 7 1
7 6 8 2
|
|---|
